Septerna (SEPN) Total Non-Current Liabilities (2023 - 2026)

Septerna's (SEPN) quarterly Total Non-Current Liabilities came in at $191.1 million in Q1 2026, up 466.7% year-on-year from $33.7 million in Q1 2025, and down 10.8% quarter-over-quarter from $214.3 million in Q4 2025.

Septerna (SEPN) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends

Septerna's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $191.1 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 466.7% year-over-year to $191.1 million in Q1 2026; TTM through Mar 2026 was $191.1 million, a 466.7% increase from a year earlier, with the FY2025 full-year figure at $214.3 million, up 487.43% from the prior year.
  • Total Non-Current Liabilities fell to $191.1 million in Q1 2026 per SEPN's latest filing, from $214.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $217.9 million in Q3 2025 and bottomed at $19.5 million in Q4 2023.
  • The 4-year median for Total Non-Current Liabilities is $37.5 million (2024), against an average of $98.5 million.
  • Across the five-year window, Total Non-Current Liabilities soared 87.24% in 2024 and soared 487.43% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $19.5 million in 2023, then soared by 87.24% to $36.5 million in 2024, then surged by 487.43% to $214.3 million in 2025, then slipped by 10.8% to $191.1 million in 2026.
  • Per Business Quant, the three latest SEPN Total Non-Current Liabilities figures stand at $191.1 million (Q1 2026), $214.3 million (Q4 2025), and $217.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Septerna 1.50 Bn 1.50 Bn - 191.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 191.13 Mn
Dec 31, 2025 214.26 Mn
Sep 30, 2025 217.92 Mn
Jun 30, 2025 37.67 Mn
Mar 31, 2025 33.73 Mn
Dec 31, 2024 36.47 Mn
Sep 30, 2024 37.34 Mn
Dec 31, 2023 19.48 Mn